Classification criteria for psoriatic arthritis: development of new criteria from a large international study
- PMID: 16871531
- DOI: 10.1002/art.21972
Classification criteria for psoriatic arthritis: development of new criteria from a large international study
Abstract
Objective: To compare the accuracy of existing classification criteria for the diagnosis of psoriatic arthritis (PsA) and to construct new criteria from observed data.
Methods: Data were collected prospectively from consecutive clinic attendees with PsA and other inflammatory arthropathies. Subjects were classified by each of 7 criteria. Sensitivity and specificity were compared using conditional logistic regression analysis. Latent class analysis was used to calculate criteria accuracy in order to confirm the validity of clinical diagnosis as the gold standard definition of "case"-ness. Classification and Regression Trees methodology and logistic regression were used to identify items for new criteria, which were then constructed using a receiver operating characteristic curve.
Results: Data were collected on 588 cases and 536 controls with rheumatoid arthritis (n = 384), ankylosing spondylitis (n = 72), undifferentiated arthritis (n = 38), connective tissue disorders (n = 14), and other diseases (n = 28). The specificity of each set of criteria was high. The sensitivity of the Vasey and Espinoza method (0.97) was similar to that of the method of McGonagle et al (0.98) and greater than that of the methods of Bennett (0.44), Moll and Wright (0.91), the European Spondylarthropathy Study Group (0.74), and Gladman et al (0.91). The CASPAR (ClASsification criteria for Psoriatic ARthritis) criteria consisted of established inflammatory articular disease with at least 3 points from the following features: current psoriasis (assigned a score of 2; all other features were assigned a score of 1), a history of psoriasis (unless current psoriasis was present), a family history of psoriasis (unless current psoriasis was present or there was a history of psoriasis), dactylitis, juxtaarticular new bone formation, rheumatoid factor negativity, and nail dystrophy. These criteria were more specific (0.987 versus 0.960) but less sensitive (0.914 versus 0.972) than those of Vasey and Espinoza.
Conclusion: The CASPAR criteria are simple and highly specific but less sensitive than the Vasey and Espinoza criteria.
Comment in
-
Are the classification criteria for psoriatic arthritis better than existing criteria for diagnosing psoriatic arthritis? Comment on the article by Taylor et al.Arthritis Rheum. 2007 Feb;56(2):699-700; author reply 700. doi: 10.1002/art.22411. Arthritis Rheum. 2007. PMID: 17265515 No abstract available.
-
Sensitivity and specificity of the CASPAR criteria for psoriatic arthritis in a family medicine clinic setting.J Rheumatol. 2008 Oct;35(10):2069-70; author reply 2070. J Rheumatol. 2008. PMID: 18843760 No abstract available.
Similar articles
-
A comparison of the performance characteristics of classification criteria for the diagnosis of psoriatic arthritis.Semin Arthritis Rheum. 2004 Dec;34(3):575-84. doi: 10.1016/j.semarthrit.2004.05.001. Semin Arthritis Rheum. 2004. PMID: 15609261
-
Clinical application of the CASPAR criteria for psoriatic arthritis compared to other existing criteria.Clin Exp Rheumatol. 2010 May-Jun;28(3):304-10. Epub 2010 Jun 23. Clin Exp Rheumatol. 2010. PMID: 20576225
-
Classification and diagnostic criteria for psoriatic arthritis.Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii3-8. doi: 10.1136/ard.2004.032318. Ann Rheum Dis. 2005. PMID: 15708931 Free PMC article. Review.
-
Proposed classification criteria of psoriatic arthritis. A preliminary study in 260 patients.Rev Rhum Engl Ed. 1999 Oct;66(10):446-56. Rev Rhum Engl Ed. 1999. PMID: 10567972 Clinical Trial.
-
[Classification of idiopathic juvenile arthritis].Tidsskr Nor Laegeforen. 2000 Feb 10;120(4):459-65. Tidsskr Nor Laegeforen. 2000. PMID: 10833937 Review. Norwegian.
Cited by
-
Study of the Gut Microbiome in Patients with Psoriatic Arthritis.Eur J Rheumatol. 2024 Sep 5;11(2):46-52. doi: 10.5152/eurjrheum.2024.23080. Eur J Rheumatol. 2024. PMID: 39576066 Free PMC article.
-
Association of achieving clinical disease control criteria and patient-reported outcomes in bimekizumab-treated patients with active psoriatic arthritis: results from two phase III studies.Ther Adv Musculoskelet Dis. 2024 Nov 11;16:1759720X241288071. doi: 10.1177/1759720X241288071. eCollection 2024. Ther Adv Musculoskelet Dis. 2024. PMID: 39534481 Free PMC article.
-
A comparison of comorbidities and their risk factors prevalence across rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis with focus on cardiovascular diseases: data from a single center real-world cohort.Rheumatol Int. 2024 Nov 11. doi: 10.1007/s00296-024-05740-z. Online ahead of print. Rheumatol Int. 2024. PMID: 39527279
-
Chronic kidney disease in patients with psoriatic arthritis: a cohort study.RMD Open. 2024 Nov 7;10(4):e004636. doi: 10.1136/rmdopen-2024-004636. RMD Open. 2024. PMID: 39510763 Free PMC article.
-
Regional variations in psoriatic arthritis: Insights from a nationwide multicenter analysis in Türkiye.Arch Rheumatol. 2024 Aug 26;39(3):339-349. doi: 10.46497/ArchRheumatol.2024.10591. eCollection 2024 Sep. Arch Rheumatol. 2024. PMID: 39507837 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
